Branded and Biosimilar Ophthalmology
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)contractFind a Tender ↗Ref ocds-h6vhtk-05826232014L0024unsuccessful
Estimated value
—
goods
Awarded value
—
Suppliers
8
3 SME
Lots
4
4 awarded
Published
24 Nov 2025
Description
Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.
Scope
- Reference
- NP33925
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
| Logistcics | 5 | quality | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 4 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
SA
Lots · 4 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Aflibercept (Eylea®) | £89.8m | cancelled |
| 2 | Aflibercept Biosimilar | £1 | cancelled |
| 3 | Ranibizumab vials and Pre-filled Syringes | £5.1m | cancelled |
| 4 | Faricimab (Vabysmo®) | £51.7m | cancelled |